• Volume of Medicines Produced1.7 BFY, 2021
  • Revenue£34.1 BFY, 2021
  • Market Capitalization£68.9 B2022-08-01

GSK Summary


GSK (GlaxoSmithKline) is a science-led healthcare company that researches, develops, and manufactures pharmaceutical medicines, vaccines, and consumer healthcare products. The company develops vaccines against infectious diseases and provides a portfolio of medicines in respiratory, HIV, immuno-inflammation, and oncology. GSK combines science and consumer insights aiming to create everyday healthcare brands for oral health, pain relief, cold, flu and allergy relief, digestive health, and vitamins, minerals, and supplements.
HQBrentford, GBMap
Employee Ratings
Overall CultureAMore


GSK is headquartered in
Brentford, United Kingdom

Location Map

Latest Updates

Company Growth (employees)

Employees (est.) (Dec 2021)90,096(-4%)
Job Openings2,510
Website Visits (Apr 2022)1 m(-15%)
Revenue (FY, 2021)£34.1 B
Share Price (Aug 2022)£16.9(-2%)
Cybersecurity ratingBMore
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.

Key People/Management at GSK

GSK Office Locations

GSK has offices in Brentford, Philadelphia, Boumerdes, San Fernando and in 88 other locations

GSK Financials and Metrics

GSK Revenue

GSK's revenue was reported to be £34.11 b in FY, 2021


Revenue (Q2, 2022)£9.45 b
Gross profit (Q2, 2022)£8.53 b
Gross profit margin (Q2, 2022), %90.2%
Net income (Q2, 2022)£975 m
EBITDA (Q2, 2022) £6.32 b
EBIT (Q2, 2022) £1.42 b
Market capitalization (01-Aug-2022)£68.89 b
Closing stock price(01-Aug-2022)£16.94
Cash (30-Jun-2022)£6.47 b
EV $84.54 b

GSK's current market capitalization is £68.9 b.

USDFY, 2019FY, 2020FY, 2021
Revenue33.8 b34.1 b34.1 b
Revenue growth, %10%1%0%
Cost of goods sold11.9 b11.7 b11.6 b
Gross profit21.9 b22.4 b22.5 b
USDQ1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021Q2, 2021Q3, 2021Q1, 2022Q2, 2022
Revenue7.7 b7.8 b9.4 b9.1 b7.6 b8.6 b7.4 b8.1 b9.1 b9.8 b9.5 b
Cost of goods sold2.7 b2.6 b3.2 b3.2 b2.4 b2.9 b2.5 b2.6 b2.9 b3.7 b(572 m)
Gross profit4.9 b5.2 b6.1 b5.9 b5.2 b5.8 b4.9 b5.5 b6.2 b6.1 b8.5 b
Gross profit Margin, %64%66%65%65%68%67%67%68%68%62%90%
show all

GBPFY, 2019FY, 2020FY, 2021
Cash4.7 b6.3 b4.3 b
Accounts Receivable7.2 b7 b7.9 b
Inventories5.9 b6 b5.8 b
Current Assets19.5 b20.2 b18.7 b
GBPQ1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021Q2, 2021Q3, 2021Q1, 2022Q2, 2022
Cash4.1 b4.1 b4.3 b4.8 b8.2 b4.3 b4.8 b3.5 b3.5 b11 b6.5 b
Accounts Receivable6.6 b6.9 b8.2 b8.5 b7.2 b7.9 b6.5 b6.9 b7.7 b8.3 b6.5 b
Prepaid Expenses413 m
Inventories5.7 b6 b6.8 b6 b6.4 b6.4 b6.2 b6.3 b6.2 b6 b4.7 b
show all

GBPFY, 2019FY, 2020FY, 2021
Net Income5.3 b6.4 b5.1 b
Depreciation and Amortization2.3 b624 m2.4 b
Accounts Receivable(32 m)(224 m)(782 m)
Inventories300 m119 m25 m
GBPQ1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021Q2, 2021Q3, 2021Q1, 2022Q2, 2022
Net Income985 m2 b3.8 b1.7 b4.1 b5.5 b1.3 b2.8 b4.2 b2.2 b2.5 b
Depreciation and Amortization1.2 b2 b2.5 b194 m(971 m)(330 m)361 m1 b2 b704 m1.3 b
Accounts Receivable0
show all

Q2, 2022
EV/EBIT74.5 x
EV/CFO25.2 x
Debt/Equity1.0 x
Debt/Assets0.2 x
Financial Leverage3.9 x
  • GSK Market Cap History

  • GSK Stock Price

Revenue Breakdown

GSK revenue breakdown by business segment: 28.2% from Consumer Healthcare, 52.0% from Global Pharmaceuticals and 19.9% from Vaccines

GSK revenue breakdown by geographic segment: 23.0% from Europe, 32.8% from International and 44.2% from US

GSK Operating Metrics

GSK's Vaccines was reported to be 767 m in FY, 2021.

FY, 2019FY, 2020FY, 2021
Phase II Trials Products1476
Healthcare Products in Development395964
Phase I Trials Products121216
Vaccine Doses Delivered per Day2 m

GSK Acquisitions / Subsidiaries

Company NameDateDeal Size
Sierra OncologyApril 13, 2022$1.9 b
Pfizer Biotech Corporation TaiwanSeptember 28, 2020£129 m
Sitari PharmaceuticalsSeptember 12, 2019
TESARODecember 04, 2018$5.1 b
GlycoVaxynFebruary 11, 2015$190 m
Okairos AGMay 29, 2013$325 m
Human Genome SciencesAugust 03, 2012$3 b
CellZomeMay 15, 2012£61 m
MaxiNutritionDecember 13, 2010£162 m
Nanjing MeiRui Pharma Co., Ltd.December 07, 2010$70 m

Human Capital Metrics


GSK Hiring Categories

GSK Median Salaries

Source: 9 public H-1B filings from GSK

GSK Cybersecurity Score

Cybersecurity ratingPremium dataset



SecurityScorecard logo

GSK Environment, Social & Governance (ESG) Ratings

CSRHub ESG ratingPremium dataset


out of 100

CSRHub logo

GSK Website Traffic

Total Visits per monthSimilarWeb

GSK Online and Social Media Presence

Twitter followers

238.7 k Twitter followers

6 Months

GSK has 238.7 k Twitter Followers. The number of followers has increased 0.30% month over month and increased 1.10% quarter over quarter.

GSK's Trends

Search term - GSK

Twitter Engagement Stats for @gsk

  • 13.31 k


  • 719


  • 238.7 k


  • 42

    Tweets last 30 days

  • 17.3

    Avg. likes per Tweet

  • 81%

    Tweets with engagement

GSK Technology StackBuildWith Logo

  • ads

    27 products used

    • Adobe Audience Manager
    • AdRoll
    • AppNexus
      • AppNexus Segment Pixel
      • Bizo
      • BlueKai
      • DeepIntent
      • DemDex
      • DoubleClick Bid Manager
      • DoubleClick.Net
      • Ezakus
      • Facebook Custom Audiences
      • Facebook Exchange FBX
      • Google Adsense
      • Google AdSense Custom Search Ads
      • Google Remarketing
      • IponWeb BidSwitch
      • JW Player Tracking
      • Openads/OpenX
      • Outbrain
      • Pubmatic
      • Rocket Fuel
      • Rubicon Project
      • The Trade Desk
      • travel audience
      • Twitter Ads
      • Yahoo Small Business
  • analytics

    46 products used

    • accessiBe
    • Adobe Analytics
    • Adobe CQ Analytics
      • Adobe Experience Platform Identity Service
      • Adobe Marketing Cloud
      • Adobe Target Standard
      • Adobe Target v2.x
      • Akamai mPulse
      • Amazon Advertising Sizmek Ad Suite
      • Bing Universal Event Tracking
      • Bizo Insights
      • Clicktools
      • Decibel Insight
      • DoubleClick Floodlight
      • Everest Technologies
      • Facebook Domain Insights
      • Facebook Pixel
      • Facebook Signal
      • Global Site Tag
      • Google Analytics
      • Google Analytics Classic
      • Google Analytics Enhanced Link Attribution
      • Google Analytics Event Tracking
      • Google Analytics IP Anonymization
      • Google Conversion Tracking
      • Google Universal Analytics
      • Hotjar
      • LinkedIn Insights
      • LiveRamp
      • Marketo
      • MediaMath
      • New Relic
      • Omniture Adobe Test and Target
      • Omniture SiteCatalyst
      • Poppulo
      • Quantcast Measurement
      • Quantum Metric
      • Rapleaf
      • Salesforce
      • Segment
      • Tealium UTAG
      • Twitter Analytics
      • Twitter Conversion Tracking
      • Twitter Website Universal Tag
      • Yahoo Dot
      • Yahoo Web Analytics
  • CDN

    15 products used

    • AJAX Libraries API
    • Akamai
    • Amazon S3
      • Azure Edge
      • BootstrapCDN
      • CDN JS
      • CloudFront
      • Cloudinary
      • Content Delivery Network
      • GStatic Google Static Content
      • Microsoft Azure Blob Storage
      • Microsoft Azure CDN
      • RawGit
      • Twitter CDN
      • Yahoo Image CDN
  • cdns

    3 products used

    • Akamai Edge
    • Amazon CloudFront
    • Amazon S3 CDN
Learn more on BuiltWith

GSK Company CultureCultureAndCompensation Logo

  • Overall Culture



  • CEO Rating



  • Compensation



  • Diversity



Learn more on Comparably

GSK News and Updates

Jul 29, 2022
$1.7 Billion Worldwide Pharmaceutical Drug Delivery Industry to 2027 - Featuring GSK, Johnson & Johnson, Novartis and Pfizer Among Others
_3xOCqDublin, July 29, 2022 (GLOBE NEWSWIRE) -- The "Pharmaceutical Drug Delivery Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to's offering. The global pharmaceutical drug delivery market reached a value of US$ 1,242.8 Billion in 2021. Looking forward, the publisher expects the market to reach a value of US$ 1,753.9 Billion by 2027, exhibiting a CAGR of 5.91% during 2021-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.Pharmaceutical drug delivery is a method of administering therapeutic substances into the body. It improves efficiency, safety, and patient experience by controlling the rate, time, and place of drug release. At present, different types of drug delivery systems are available for the release of various therapeutic agents. For instance, gels, liposomes, microspheres, prodrugs, and cyclodextrins are among the effective systems used for peptide and protein therapeutics.Pharmaceutical Drug Delivery Market Trends:
Jul 27, 2022
Dow Jones Newswires: GSK second quarter profit dips to $1.3 billion but raises outlook for rest of year
_3xOCqBritish pharmaceutical major posted operating profit of £1.08 billion pounds ($1.30 billion) for the period, down from £1.28 billion the year prior.
Jul 26, 2022
GSK Pharma Q1 Review - In-Line; Focus Remain On Rx Growth: Centrum Broking
_3xOCqGSK Pharma Q1 Review - In-Line; Focus Remain On Rx Growth: Centrum Broking
Jul 26, 2022
UAE Oral Care Markets Report 2022 Featuring 3M Medical UAE, P&G UAE, GSK UAE, Colgate Palmolive UAE, Philips UAE, Ansar Harford FZC, & Biofresh Healthcare Products
_3xOCqDublin, July 26, 2022 (GLOBE NEWSWIRE) -- The "UAE Oral Care Market, By Type (Toothpaste, Toothbrush, Mouthwashes/Rinses, Dental Accessories, Denture Products, Others), By Distribution Channel, By End User, By Region, Competition Forecast & Opportunities, 2017-2027" report has been added to's offering.
Jul 26, 2022
GSK Pharma Q1 Review - Pain, Vaccine Therapies Hinder Revenue Growth: Motilal Oswal
_3xOCqGSK Pharma Q1 Review - Pain, Vaccine Therapies Hinder Revenue Growth: Motilal Oswal
Jul 18, 2022
GSK spinoff Haleon starts trading in largest European listing in a decade
_3xOCqEurope's biggest listing in a decade, Haleon, started trading on the London Stock Exchange on Monday. Haleon in the consumer-health business spinoff of GSK . The combined price of Haleon, 331.7 pence, and the remaining GSK, 1,383.40 pence, of 1715.10 pence, compares to GSK's Friday close of 1,719.20 pence. Haleon will start trading on a when-issued basis on the New York Stock Exchange on Monday, with full trading slated for Friday.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit for more information on this news.

GSK Blogs

You may also be interested in Related companies

Bologna, IT
1699  1increase
Alfasigma is a pharmaceutical company providing prescription and over-the-counter drugs.
View company
EFFIK International
Anderlecht, BE
222  2increase
EFFIK International is a pharmaceutical laboratory.
View company
Ozon Pharm
Zhigulevsk, RU
Ozon Pharm is a pharmaceutical company that manufactures medicines.
View company
Laurus Labs
Hyderabad, IN
Laurus Labs is a pharmaceutical company.
View company
When was GSK founded?
GSK was founded in 2000.
Who are GSK key executives?
GSK's key executives are Emma Walmsley, Iain MacKay and Hal Barron.
How many employees does GSK have?
GSK has 90,096 employees.
What is GSK revenue?
Latest GSK annual revenue is £34.11 b.
What is GSK revenue per employee?
Latest GSK revenue per employee is £378.64 k.
Who are GSK competitors?
Competitors of GSK include Pfizer, Merck and Johnson & Johnson.
Where is GSK headquarters?
GSK headquarters is located at 980 Great West Rd, Brentford.
Where are GSK offices?
GSK has offices in Brentford, Philadelphia, Boumerdes, San Fernando and 88 other locations
How many offices does GSK have?
GSK has 99 offices.

Craft real-time company insights

Learn about Craft real-time company insights

Receive alerts for 300+ data fields across thousands of companies

Footer menu